Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or OpenAthens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Current Urology

International Journal of Shandong University

Guidelines for Authors
www.karger.com/cur_guidelines

Submission
Conditions
Cover Letter
Plagiarism Policy
Arrangement
Color Illustrations
References
Proofs
Reprints
Self-Archiving/Green Open Access, Author's ChoiceTM,
   Funding Organizations (NIH etc.)




Submission

Manuscripts written in English should be submitted online

Online Manuscript Submission

or as e-mail attachment (the preferred word-processing package is MS-Word) to the Editorial Office:

xiaoleifang@sdu.edu.cn

Editorial Office 'Current Urology'
Institute of Urology
Shandong University
247 Beiyuan Road
Jinan, Shandong, 250033
China
Tel. +86 531 85875737
Fax +86 531 85875736

The manuscripts should be accompanied by a signed cover letter addressing the points below.A signed copyright transfer statement is required upon acceptance (downloadable from the online submission website).




Conditions

All manuscripts are subject to editorial review. Manuscripts are received with the explicit understanding that they are not under simultaneous consideration by any other publication. Submission of an article for publication implies the transfer of the copyright from the author to the publisher upon acceptance. Accepted papers become the permanent property of 'Current Urology' and may not be reproduced by any means, in whole or in part, without the written consent of the publisher. It is the author's responsibility to obtain permission to reproduce illustrations, tables, etc. from other publications.
For legal reasons, we must receive your 'Submission Statement' with your original (hand-written) signature. Please download, print, sign and either fax or scan it to make it legally binding.

Conflict of Interest: All forms of support, including that from drug companies, and any potential source of conflict of interest should be acknowledged in the cover letter to the editor when applicable. The statement will be printed at the end of the article.

Ethics: Published research must comply with the guidelines for human studies and animal welfare regulations. Authors should state that subjects have given their informed consent and that the study protocol has been approved by the institute's committee on human research. Further, they should also state that animal experiments conform to institutional standards.




Cover Letter

The cover letter must include statements on the following points:
1. All authors have made a significant contribution to the findings and methods in the
   paper.
2. All authors have read and approved the final draft.
3. Financial or commercial interest must be acknowledged.
4. The work has not already been published and has not been submitted simultaneously to any other journal.
5. The corresponding author takes on the above responsibilities with his/her signature.




Plagiarism Policy

Whether intentional or not, plagiarism is a serious violation. We define plagiarism as a case in which a paper reproduces another work with at least 25% similarity and without citation.
If evidence of plagiarism is found before/after acceptance or after publication of the paper, the author will be offered a chance for rebuttal. If the arguments are not found to be satisfactory, the manuscript will be retracted and the author sanctioned from publishing papers for a period to be determined by the responsible Editor(s).




Arrangement

Title page: The first page of each paper should indicate the title, the authors' names and the institute where the work was conducted.In addition, the following should be put on the title page:
  1. Short title for use as running head.
  2. A list of 3-10 key words for indexing purposes is essential.
  3. Corresponding author: One of the authors has to be indicated as the
      corresponding author. The full name and complete mailing address, e-mail
      address, as well as phone and fax numbers of that individual to whom
      correspondence, PDF proofs, and requests for reprints should be
      addressed, must be given at the bottom of the title page.

Abstract: Each paper must have a structured abstract (Introduction, Materials and Methods, Results and Conclusions) of up to 20 lines (approximately 150 words). Abstracts of case reports need not be structured.

Footnotes: Avoid footnotes. When essential, they are numbered consecutively and typed at the foot of the appropriate page.

Tables and illustrations: Tables and illustrations (both numbered in Arabic numerals) should be prepared on separate pages. Tables require a heading and figures a legend, also prepared on a separate page. For technical reasons, figures with a screen background should not be submitted. When possible, group several illustrations in one block for reproduction (max. size 180 x 223 mm) or provide crop marks.Electronically submitted b/w half-tone and color illustrations must have a final resolution of 300 dpi after scaling, line drawings one of 800-1,200 dpi. Figure files must not be embedded in a document file but submitted separately (for more details see Technical Instructions.

Case Reports should include the most important clinical details and not exceed 1,000 words. One table and two figures may be included. References should be limited to ten.

Letters to the Editor must include matters of interest to urologists and not exceed 500 words.




Color Illustrations

Online edition: Color illustrations are reproduced free of charge. In the print version, the illustrations are reproduced in black and white. Please avoid referring to the colors in the text and figure legends.
Print edition: Up to 6 color illustrations per page can be integrated within the text at CHF/USD 500.00 per page.




References

In the text identify references by Arabic numerals [in square brackets]. Material submitted for publication but not yet accepted should be noted as 'unpublished data' and not be included in the reference list. The list of references should include only those publications which are cited in the text. Do not alphabetize; number references in the order in which they are first mentioned in the text. The surnames of the authors followed by initials should be given. There should be no punctuation other than a comma to separate the authors. Preferably, please cite all authors. Abbreviate journal names according to the Index Medicus system. Also see International Committee of Medical Journal Editors: Uniform requirements for manuscripts submitted to biomedical journals (www.icmje.org).

Digital Object Identifier (DOI)
S. Karger Publishers supports DOIs as unique identifiers for articles. A DOI number will be printed on the title page of each article. DOIs can be useful in the future for identifying and citing articles published online without volume or issue information. More information can be found at www.doi.org
Examples

(a) Papers published in periodicals:
Sun J, Koto H, Chung KF: Interaction of ozone and allergen challenges on bronchial responsiveness and inflammation in sensitised guinea pigs. Int Arch Allergy Immunol 1997;112:191-195.

(b) Papers published only with DOI numbers:
Theoharides TC, Boucher W, Spear K: Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients. Int Arch Allergy Immunol DOI: 10.1159/000063858.

(c) Monographs:
Matthews DE, Farewell VT: Using and Understanding Medical Statistics,
ed 3, revised. Basel, Karger, 1996.

(d) Edited books:
Parren PWHI, Burton DR: Antibodies against HIV-1 from phage display libraries: Mapping of an immune response and progress towards antiviral immunotherapy; in Capra JD (ed): Antibody Engineering. Chem Immunol. Basel, Karger, 1997, vol 65, pp 18-56.




Proofs

PDF proofs are sent to the corresponding author and should be returned with the least possible delay.




Reprints

Order forms and a price list are sent with the PDF proofs. Orders submitted after the issue is printed are subject to considerably higher prices.




Self-Archiving/Green Open Access

Karger permits authors to archive their pre-prints (i.e. pre-peer review) or post-prints (i.e. accepted manuscript after peer review but before production) on their personal or their institution’s internal website. In addition, authors may post their accepted manuscripts in public Open Access repositories and scientific networks (e.g. ResearchGate or Mendeley) no earlier than 12 months following publication of the final version of their article. For all self-archiving, the posted manuscripts must:

  • Be used for noncommercial purposes only
  • Be linked to the final version on www.karger.com
  • Include the following statement:

‘This is the peer-reviewed but unedited manuscript version of the following article: [insert full citation, e.g. Cytogenet Genome Res 2014;142:227–238 (DOI: 10.1159/000361001)]. The final, published version is available at http://www.karger.com/?doi=[insert DOI number].’

It is the author’s responsibility to fulfill these requirements.

For papers published online first with a DOI number only, full citation details must be added as soon as the paper is published in its final version. This is important to ensure that citations can be credited to the article.

Manuscripts to be archived in PubMed Central due to funding requirements will be submitted by Karger on the author’s behalf [see Funding Organizations (NIH etc.)].

For self-archiving Author's ChoiceTM (Gold Open Access) articles, see Author's ChoiceTM.


Author's ChoiceTM

Karger’s Author's ChoiceTM service broadens the reach of your article and gives all users worldwide free and full access for reading, downloading and printing at www.karger.com. The option is available for a one-time fee of CHF 3,000.00, which is a permissible cost in grant allocation. More information can be found at www.karger.com/authors_choice.
The final, published version of the article may be posted at any time and in any repository or on other websites, in accordance with the relevant Creative Commons license. Reposted Open Access articles must:

  • Follow the terms of the relevant Creative Commons license
  • Be linked to the final version on www.karger.com
  • Include the following statement:

‘The final, published version of this article is available at http://www.karger.com/?doi=[insert DOI number].’

It is the author’s responsibility to fulfill these requirements.

For papers published online first with a DOI number only, full citation details must be added as soon as the paper is published in its final version. This is important to ensure that citations can be credited to the article.


Funding Organizations (NIH etc.)

The U.S. National Institutes of Health (NIH) Public Access Policy mandates that accepted, peer-reviewed manuscripts are archived in its digital database, PubMed Central (PMC), within 12 months of the official publication date. As a service to authors, Karger submits NIH-funded articles to PMC on behalf of the authors immediately upon publication. The NIH assigns a PMCID within approximately 1 month and the manuscript will appear in PMC after a 12-month embargo. For authors making their paper Open Access through Author's ChoiceTM, the embargo will be overridden, thereby accelerating the accessibility of the article. Karger also complies with other funders’ requirements (including Wellcome Trust and RCUK) for submission to PMC.
Authors should include information on their grant in the Acknowledgements section of their papers.